Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Oct;52(10):711–715. doi: 10.1136/ard.52.10.711

Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.

K L Faarvang 1, C Egsmose 1, P Kryger 1, J Pødenphant 1, M Ingeman-Nielsen 1, T M Hansen 1
PMCID: PMC1005166  PMID: 7903034

Abstract

OBJECTIVES--To compare the effects of hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis. METHODS--A six month randomised, multicentre, double blind trial with three parallel groups was performed. Ninety one outpatients with active rheumatoid arthritis were included. Monthly assessments of erythrocyte sedimentation rate, morning stiffness, number of swollen joints, a pain score, and global assessments were carried out. Radiographs of hands and wrists were taken before and after the trial. RESULTS--Sixty two patients completed the study. The 29 withdrawals caused no evident bias, and there was no difference in side effects among the three groups. All variables improved significantly with time. Patients treated with a combination of hydroxychloroquine and sulphasalazine responded better and faster than those treated with hydroxychloroquine alone, but there was no statistically significant difference between the combination treatment and single drug treatment with sulphasalazine or between treatment with hydroxychloroquine and sulphasalazine given alone. CONCLUSION--The present results do not support a recommendation to use a combination of hydroxychloroquine and sulphasalazine in the treatment of rheumatoid arthritis.

Full text

PDF
711

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bentzon M. W., Gad I., Halberg P., Halskov O., Jacobsen B. K., Lorenzen I., Morling N., Svejgaard A. Influence of previous gold treatment and other patient variables on outcome of treatment with disease modifying anti-rheumatic drugs (DMARD) in patients with rheumatoid arthritis. Clin Rheumatol. 1986 Jan;5(1):39–48. doi: 10.1007/BF02030966. [DOI] [PubMed] [Google Scholar]
  2. Boers M., Ramsden M. Long acting drug combinations in rheumatoid arthritis: a formal overview. J Rheumatol. 1991 Mar;18(3):316–324. [PubMed] [Google Scholar]
  3. Bunch T. W., O'Duffy J. D., Tompkins R. B., O'Fallon W. M. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum. 1984 Mar;27(3):267–276. doi: 10.1002/art.1780270304. [DOI] [PubMed] [Google Scholar]
  4. Csuka M., Carrera G. F., McCarty D. J. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. JAMA. 1986 May 2;255(17):2315–2319. [PubMed] [Google Scholar]
  5. Gibson T., Emery P., Armstrong R. D., Crisp A. J., Panayi G. S. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study. Br J Rheumatol. 1987 Aug;26(4):279–284. doi: 10.1093/rheumatology/26.4.279. [DOI] [PubMed] [Google Scholar]
  6. Ingeman-Nielsen M., Halskov O., Hansen T. M., Halberg P., Stage P., Lorenzen I. Clinical synovitis and radiological lesions in rheumatoid arthritis. A prospective study of 25 patients during treatment with remission-inducing drugs. Scand J Rheumatol. 1983;12(3):237–240. doi: 10.3109/03009748309098540. [DOI] [PubMed] [Google Scholar]
  7. Matsubara T., Ziff M. Basement membrane thickening of postcapillary venules and capillaries in rheumatoid synovium. Immunoelectron microscopic and electron microscopic morphometric analysis. Arthritis Rheum. 1987 Jan;30(1):18–30. doi: 10.1002/art.1780300103. [DOI] [PubMed] [Google Scholar]
  8. McCarty D. J., Carrera G. F. Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. JAMA. 1982 Oct 8;248(14):1718–1723. doi: 10.1001/jama.248.14.1718. [DOI] [PubMed] [Google Scholar]
  9. Paulus H. E. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Arthritis Rheum. 1990 Jan;33(1):113–120. doi: 10.1002/art.1780330116. [DOI] [PubMed] [Google Scholar]
  10. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  11. SIEVERS K., HURRI L. Combined therapy of rheumatoid arthritis with gold and chloroquine. I. Evaluation of the therapeutic effect. Acta Rheumatol Scand. 1963;9:48–55. [PubMed] [Google Scholar]
  12. Taggart A. J., Hill J., Astbury C., Dixon J. S., Bird H. A., Wright V. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis. Br J Rheumatol. 1987 Feb;26(1):32–36. doi: 10.1093/rheumatology/26.1.32. [DOI] [PubMed] [Google Scholar]
  13. Williams H. J., Ward J. R., Reading J. C., Brooks R. H., Clegg D. O., Skosey J. L., Weisman M. H., Willkens R. F., Singer J. Z., Alarcón G. S. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum. 1992 Mar;35(3):259–269. doi: 10.1002/art.1780350304. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES